Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04661137. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03314181. IPD Sharing: YES. Countries: 7. Publications: 1.
Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
ClinicalTrials.gov study NCT02655458. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
ClinicalTrials.gov study NCT01365559. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
ClinicalTrials.gov study NCT00259740. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for Hi
ClinicalTrials.gov study NCT03217812. IPD Sharing: Not stated. Countries: 5. Publications: 3.
A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02497378. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
ClinicalTrials.gov study NCT00761722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)
ClinicalTrials.gov study NCT02576977. IPD Sharing: YES. Countries: 0. Publications: 2.
Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive
ClinicalTrials.gov study NCT03992170. IPD Sharing: NO. Countries: 1. Publications: 35.
Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects
ClinicalTrials.gov study NCT01091831. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01045681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02415413. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
ClinicalTrials.gov study NCT00335348. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers
ClinicalTrials.gov study NCT01476137. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
ClinicalTrials.gov study NCT04561492. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe
ClinicalTrials.gov study NCT03091127. IPD Sharing: YES. Countries: 11. Publications: 2.
Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
ClinicalTrials.gov study NCT04140162. IPD Sharing: NO. Countries: 1. Publications: 2.
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
ClinicalTrials.gov study NCT04582539. IPD Sharing: YES. Countries: 3. Publications: 0.
Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy
ClinicalTrials.gov study NCT03993912. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.